✦ LIBER ✦
Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study
✍ Scribed by Clemons, Mark J.; Cochrane, Brandy; Pond, Gregory R.; Califaretti, Nadia; Chia, Stephen K. L.; Dent, Rebecca Alexandra; Song, Xinni; Robidoux, Andre; Parpia, Sameer; Warr, David; Rayson, Daniel; Pritchard, Kathleen I.; Levine, Mark N.
- Book ID
- 125356857
- Publisher
- Springer US
- Year
- 2014
- Tongue
- English
- Weight
- 538 KB
- Volume
- 146
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.